
Please try another search
Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests. The company offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, and tumor stage, as well as calculates the P-score. Its test is based on database containing prostate cancer patients; and provides decision support for patients and doctors when making a treatment decision. The company was incorporated in 2007 and is headquartered in Solna, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Anders Lundberg | - | 2017 | Independent Chairman of the Board |
Jörgen Dahlström | - | 2023 | Independent Director |
Michael Haggman | - | 2018 | Independent Director |
Mattias Prage | - | 2022 | Independent Director |
Rolf Skoglund | - | - | Member of Advisory Board |
Hakan Englund | 72 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review